| Investments: |
| Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $330,903 and $317,617, respectively; includes $3,357 and $3,330, respectively, relating to variable interest entities) |
374.29B |
| Equity securities available-for-sale, at estimated fair value (cost: $3,128 and $3,621, respectively) |
3.19B |
| Trading and other securities, at estimated fair value (includes $560 and $463, respectively, of actively traded securities; and $359 and $387, respectively, relating to variable interest entities) |
| Mortgage loans: |
| Held-for-investment, principally at amortized cost (net of valuation allowances of $566 and $664, respectively; includes $6,697 and $6,840, respectively, at estimated fair value, relating to variable interest entities) |
55.34B |
| Held-for-sale, principally at estimated fair value |
271M |
| Mortgage loans, net |
55.61B |
| Policy loans |
11.78B |
| Real estate and real estate joint ventures (includes $15 and $10, respectively, relating to variable interest entities) |
10B |
| Other limited partnership interests (includes $331 and $298, respectively, relating to variable interest entities) |
7.09B |
| Short-term investments, principally at estimated fair value |
13.65B |
| Other invested assets, principally at estimated fair value (includes $98 and $104, respectively, relating to variable interest entities) |
20.27B |
| Total investments |
512.47B |
| Cash and cash equivalents, principally at estimated fair value (includes $65 and $69, respectively, relating to variable interest entities) |
9.98B |
| Accrued investment income (includes $34 and $34, respectively, relating to variable interest entities) |
4.56B |
| Premiums, reinsurance and other receivables (includes $2 and $2, respectively, relating to variable interest entities) |
23.05B |
| Deferred policy acquisition costs and value of business acquired |
24.65B |
| Goodwill |
9.7B |
| Other assets (includes $7 and $6, respectively, relating to variable interest entities) |
8.06B |
| Assets of subsidiaries held-for-sale |
| Separate account assets |
249.22B |
| Total assets |
841.69B |
| Liabilities |
| Future policy benefits |
190.05B |
| Policyholder account balances |
224.04B |
| Other policy-related balances |
15.47B |
| Policyholder dividends payable |
713M |
| Policyholder dividend obligation |
3.6B |
| Payables for collateral under securities loaned and other transactions |
| Bank deposits |
0 |
| Short-term debt |
100M |
| Long-term debt (includes $6,569 and $6,902, respectively, at estimated fair value, relating to variable interest entities) |
| Collateral financing arrangements |
4.2B |
| Junior subordinated debt securities |
3.19B |
| Current income tax payable |
231M |
| Deferred income tax liability |
| Other liabilities (includes $82 and $93, respectively, relating to variable interest entities) |
24.26B |
| Liabilities of subsidiaries held-for-sale |
| Separate account liabilities |
249.22B |
| Total liabilities |
776.72B |
| Contingencies, Commitments and Guarantees (Note 8) |
| Redeemable noncontrolling interests in partially owned consolidated subsidiaries |
| MetLife, Inc.'s stockholders' equity: |
| Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,060,584,995 and 989,031,704 shares issued at June 30, 2011 and December 31, 2010, respectively; 1,057,391,108 and 985,837,817 shares outstanding at June 30, 2011 and December 31, 2010, respectively |
11M |
| Additional paid-in capital |
28.07B |
| Retained earnings |
25.96B |
| Treasury stock, at cost; 3,193,887 shares at June 30, 2011 and December 31, 2010 |
-172M |
| Accumulated other comprehensive income (loss) |
10.58B |
| Total MetLife, Inc.'s stockholders' equity |
64.45B |
| Noncontrolling interests |
422M |
| Total equity |
64.87B |
| Total liabilities and equity |
841.69B |
| Noncumulative Preferred Stock |
| MetLife, Inc.'s stockholders' equity: |
| Preferred Stock |
1M |
| Total equity |
| Convertible Preferred Stock |
| MetLife, Inc.'s stockholders' equity: |
| Preferred Stock |
| Total equity |
